Abstract:Background Angiogenesis is one of the mechanisms most critical to the postoperative recurrence and metastasis of hepatocellular carcinoma (HCC). Thus, finding the molecular markers associated with angiogenesis may help identify patients at increased risk for recurrence and metastasis of HCC. This study was designed to investigate whether CD105 or CD34 could serve as a valid prognostic marker in patients with HCC by determining if there is a correlation between CD105 or CD34 expression and postoperative recurrence or metastasis. Methods Immunohistochemical staining for the CD105, CD34 and vascular endothelial growth factor (VEGF) antibodies was performed in 113 HCC tissue specimens containing paracarcinomatous tissue and in 14 normal liver tissue specimens. The quantitation of microvessels identified by anti-CD105 and anti-CD34 monoclonal antibodies and the semiquantitation of VEGF expression identified by anti-VEGF monoclonal antibody were analyzed in conjunction with the clinicopathological characteristics of the HCC and any available follow-up information about the patients from whom the specimens were obtained. Results CD105 was not expressed in the vascular endothelial cells of any normal liver tissue or paracarcinomatous liver tissue but was expressed in the vascular endothelial cells of all HCC tissue. In contrast, CD34 was expressed in the vascular endothelial cells of normal liver tissue, paracarcinomatous tissue, and HCC tissue in the following proportions of specimens: 86.7%, 93.8%, and 100%, respectively. The microvascular densities (MVDs) of HCC determined by using an anti-CD105 mAb (CD105-MVD) and an anti-CD34 mAb (CD34-MVD), were 71.7 ± 8.3 (SD) and 106.3 ± 10.4 (SD), respectively. There was a significant correlation between CD105-MVD and CD34-MVD ( r = 0.248, P = 0.021). Although CD34-MVD was significantly correlated with VEGF expression ( r = 0.243, P = 0.024), CD105-MVD was more closely correlated ( r = 0.300, P= 0.005). The correlation between microscopic venous invasion and CD105-MVD, but not CD34-MVD, was also statistically significant ( r = 0.254, P = 0.018). Univariate analysis showed that CD105-MVD was significantly correlated with the 2-year overall survival rate ( P = 0.014); CD34-MVD was not ( P = 0.601). Multivariate analysis confirmed that CD105-MVD was an independent prognostic factor and that CD34-MVD was not. Conclusion The anti-CD105 mAb is an ideal instrument to quantify new microvessels in HCC as compared with anti-CD34 mAb. CD105-MVD as compared with CD34-MVD is relevant a significant and independent prognostic indicator for recurrence and metastasis in HCC patients.

Significance of CD105 expression in laryngeal carcinoma

[Relevance of Endoglin (CD105) VEGF and P53 with Invasion Metastasis and Prognosis of Laryngeal Carcinoma].

Prognostic Significance of CD105- and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma

Study on the Expression and Clinical Significance of CD105 in Pancreatic Carcinoma

Expression of CD105 and D2-40 in pancreatic carcinoma and their clinical significance

[Study on the Relationship Between Microvascular Density and Prognosis in Laryngeal Cancer].

Relationship Between Expression Of Cd105 And Growth Factors In Malignant Tumors Of Gastrointestinal Tract And Its Significance

Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.

Overexpressions of DLL4 and CD105 Are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma

The Expression and Relationship of CD68-Tumor-Associated Macrophages and Microvascular Density with the Prognosis of Patients with Laryngeal Squamous Cell Carcinoma.

Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma

Quantification of Microvascular Dentsity and Cell Nuclear DNA Content in Laryngeal Cancer

[Tumor Lymphangiogenesis in Cervical Squamous Cell Carcinoma and Its Clinical Significance].

The Relationship Between the Microvessel Density and Clinical Pathologic Status in Patients with Esophageal Carcinoma

Expression of Lymphatic Vessel Endothelial Hyaluronan Receptor-1 and Vascular Endothelial Growth Factor-C in Laryngeal Squamous Cell Carcinomas

The Significance of Microvessel Density and CD34 Expression in Nasopharyngeal Carcinoma

Predictivevalue of VEGF,PDGF and MVD in Primary Laryngeal Carcinoma

[Clinical Significance of Lymph Vessel Density Marked by Lymphatic Vessel Endothelial Hyaluronic Acid Receptor-1 in Laryngeal Squamous Cell Carcinomas].

[A Study of Intratumor Microvessel Density and Lymph Node Micrometastases of Pn0 Supraglottic Laryngeal Squamous Cell Carcinoma].

Expression of VEGF in Laryngeal Squamous Cell Carcinomas and Its Clinical Significance

[Expression of angiopoietin-1,2 and its relationship with angiogenesis in laryngeal squamous cell carcinoma]